CERS
Cerus Corp.

4,411
Mkt Cap
$499.43M
Volume
1.83M
52W High
$2.96
52W Low
$1.12
PE Ratio
-30.70
CERS Fundamentals
Price
$2.60
Prev Close
$2.74
Open
$2.74
50D MA
$1.95
Beta
1.88
Avg. Volume
1.57M
EPS (Annual)
-$0.1133
P/B
8.12
Rev/Employee
$641,530.25
Loading...
Loading...
News
all
press releases
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving Average - Should You Sell?
Cerus (NASDAQ:CERS) Stock Passes Above 200 Day Moving Average - What's Next...
MarketBeat·17d ago
News Placeholder
More News
News Placeholder
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving Average - What's Next?
Cerus (NASDAQ:CERS) Stock Crosses Above 200-Day Moving Average - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S. BCA member...
Business Wire·1mo ago
News Placeholder
Cerus (NASDAQ:CERS) Stock Crosses Above 200 Day Moving Average - Should You Sell?
Cerus (NASDAQ:CERS) Shares Pass Above 200 Day Moving Average - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Cerus (NASDAQ:CERS) Raised to Buy at Wall Street Zen
Wall Street Zen upgraded Cerus from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·2mo ago
News Placeholder
Cerus (NASDAQ:CERS) Announces Quarterly Earnings Results
Cerus (NASDAQ:CERS - Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported $0.00 earnings per share for the quarter, beating the consensus estimate...
MarketBeat·2mo ago
News Placeholder
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update. We continue to make great strides in improving the...
Business Wire·2mo ago
News Placeholder
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commonly referred to as INTERCEPT...
Business Wire·3mo ago
News Placeholder
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will...
Business Wire·3mo ago
<
...
1
>

Latest CERS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.